Reuters logo
BRIEF-IBA, SK Capital reach settlement on IBA Molecular
December 11, 2013 / 6:11 AM / 4 years ago

BRIEF-IBA, SK Capital reach settlement on IBA Molecular

BRUSSELS, Dec 11 (Reuters) - Ion Beam Applications SA : * Says IBA and sk capital reach agreement on a full and final settlement * Full and final settlement for all outstanding claims and counterclaims

regarding IBA molecular * Agreement remains subject to approval of the final documentation by the

respective boards of companies * Have agreed on the way they will co-manage joint participation in IBA

molecular compounds development sàrl in future * Says future expected expenses will result in an exceptional loss of around

EUR 5 million * Says management still confirms its guidance for a positive result for 2013 * Iba-co will sell to sk rose sarl for one euro the EUR 10 million bridge note

co had got for IBA molecular sale

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below